Don’t make investments until you’re ready to lose all the cash you make investments. It is a excessive danger funding and you’re unlikely to be protected if one thing goes incorrect. Take 2 minutes to be taught extra.
Occuity is utilizing the attention as a window on the well being of the physique. They’re on a mission to enhance the lives of lots of of thousands and thousands of individuals by revolutionising how a number of the world’s most prevalent illnesses, equivalent to diabetes, myopia and Alzheimer’s, are detected and managed.
Finally, Occuity plan for merchandise, equivalent to a non-invasive glucose meter, The Occuity Indigo, to switch painful, repetitive, and invasive blood exams, with a easy, pain-free and fast, scan of the attention.
We sat down with founders Dr. Dan Daly and Dr. Robin Taylor to seek out out extra.
We’d like to find out about your careers earlier than Occuity and the place you first discovered that entrepreneurial spark.
Dr. Dan Daly: My background is in physics, optics particularly. I spent a lot of years doing bench analysis in making micro-optics (very small optical programs) then turned extra concerned in managing initiatives and the industrial points of turning expertise into merchandise.
I’d at all times wished to make use of my technical data to do one thing new and worthwhile. So the thought of utilizing gentle to make pain-free measurements for diabetes care impressed me to discovered a begin up.
Dr. Robin Taylor: I’ve at all times had a ardour for engineering since I used to be very younger. I had a deep fascination of how issues labored, why they have been constructed the best way they have been, and the way they may very well be improved. This fascination is admittedly what has been the driving power behind the multidisciplinary nature of my profession beginning with my diploma in Electro-mechanical Engineering.
It was whereas finding out my diploma that my curiosity in medical engineering started. I used to be at all times all in favour of robotics, or extra particularly animatronics. I had a member of the family that made prosthetic limbs and had visions of designing absolutely articulated robotic limbs. Electro-mechanical engineering appeared like a pure selection and my curiosity in medical engineering grew from there.
I then went on to do a PhD in biomedical engineering, after which I used to be launched to Dan. We hit it off after which spent a lot of years creating the expertise platform on which Occuity’s merchandise are based mostly. When the chance to setup our personal firm and drive our personal merchandise right into a market we’re each so captivated with introduced itself, we jumped on the probability.
Inform us concerning the enterprise – what it’s, what it goals to realize, who you’re employed with, the way you attain clients and so forth?
Dr. Dan Daly: Our mission is to enhance the lives of thousands and thousands of individuals globally, by delivering non-invasive screening and monitoring options to switch invasive and infrequently repetitive exams. It’s cellular, so may be taken to the affected person and utilized in non-clinical settings.
We’re constructing a expertise platform on which we’ll construct a lot of totally different gadgets for various markets. We have now each nice quick time period merchandise, to unravel rapid market wants, and limitless future alternatives, to actually use the attention as a window on the well being of the physique.
We’re focusing on a wide range of audiences beginning with buy gross sales to B2B clients with our ophthalmic gadgets and progressively transitioning to B2C clients and a MMR (Month-to-month Recurring Income) Mannequin for our diabetes monitoring gadgets
What’s Occuity and what drawback are you fixing?
Dr. Robin Taylor: Our expertise makes use of gentle to make measurements within the eye. It’s protected, compact and value efficient and has quite a few purposes. Our purpose is for Occuity to develop a collection of gadgets that may supply a broad vary of screening, diagnostic and monitoring capabilities. We have now a powerful give attention to ease of use and, by their very nature, these gadgets will facilitate simpler entry to those capabilities ordinarily solely present in hospitals. It’s my hope that this may result in a step change within the remedy of persistent illnesses by utilizing screening to establish these in danger earlier than these situations progress to the purpose that extra intensive remedy is required.
Nice examples of this are the AX1 and our diabetes screening undertaking, the SD1. Healthcare screening is one thing I’m very captivated with and I’m very enthusiastic about each this increase, and the latest Innovate UK grant we’ve been awarded to allow us to push these initiatives ahead.
How has the enterprise advanced since its launch? When was this?
Dr. Dan Daly: The enterprise was based in 2019. Regardless of the pandemic and international provide chain points, we’ve grown considerably over the previous few years. We have now recruited a extremely certified crew, and expanded our deliberate product vary with some actually thrilling discoveries.
We’re very near getting our first product to market, which shall be a key milestone. Nevertheless, while everyone knows that may be a essential inflexion level for the enterprise, it’s equally necessary to notice that we’re not constructing one product, we’re constructing a expertise platform, which is able to allow us to develop many merchandise. This has already borne fruit, within the form of the AX1. The response from the market to the potential of the AX1 has been unbelievable.
What are you able to inform us concerning the market and the way Occuity is positioning themselves for achievement?
Dr. Dan Daly: We’re focusing on three separate markets with a transparent technique. Our first merchandise, for ophthalmic use, shall be disruptive attributable to their ease of use, their non-invasive and compact design, and in addition their low price-point. These are near market and can generate invaluable revenues within the quick time period. These preliminary merchandise may even present the foundations on which we’ll construct our really modern medium to long run options that may tackle the screening and monitoring challenges that at present depend on invasive blood exams. These will, after all, be knottier challenges, however supply far bigger potential returns.
Might you inform us about a few of your largest achievements thus far?
Dr. Dan Daly: There are such a lot of issues I may point out, the patents, the crew, turning into the most important MedTech increase on Seedrs, however I’ll give attention to three particular issues of which we’re notably proud:
- Thames Valley Tech Awards – Begin Up of the Yr – It was extremely aggressive and highlighted that individuals may see the potential of our expertise.
- Future Leaders Fellowship – We secured a £1.4m grant, which suggests we will undertake some innovative analysis which is able to assist our work on the screening gadgets for diabetes and Alzheimer’s Illness.
- AX1 – I spotlight this, as a result of I imagine it’s the finest instance of how the corporate is admittedly coming collectively. New alternatives just like the AX1, are one thing I count on to come up from different areas of our work.
How do you propose to create a scalable and worthwhile enterprise mannequin?
Dr. Dan Daly: We have now a transparent technique and plan. We have now a patented expertise platform and a pipeline of merchandise which are tackling international healthcare challenges. We plan to get to market with our first ophthalmic merchandise to ship income and show the capabilities of the platform, earlier than transitioning by way of our screening and monitoring gadgets to a Gadget as a Service mannequin, to permit us to ship considerably month-to-month recurring revenues and really wholesome margins.
Our enterprise mannequin demonstrates that we’re assured Occuity can change into a unicorn and ship a really vital return for shareholders.
What do you propose to do with the cash you increase?
Dr. Dan Daly: The cash raised on this spherical shall be used to get the PM1 to market and to speed up the event of the AX1 in addition to the underlying expertise platform. There’s such enormous demand (that may solely develop) for the AX1 proper now, that we all know it is very important get to market as quickly as we will.
What do you like to do in your free time?
Dr. Dan Daly: I are likely to take pleasure in sensible initiatives and have an curiosity in traditional vehicles. I’ve a half share in a ‘60s coupe {that a} pal and I are getting ready for traditional rallies.
Dr. Robin Taylor: I’m firstly a dad, after which an engineer, so when I’m not spending time with the household I’m tinkering in my lab (the storage). I’m very captivated with our expertise and what we do at Occuity so I spend a lot of my spare time pushing our expertise ahead, pushing the boundaries of what we will do and to offer us one of the best probability of succeeding.
If you happen to weren’t constructing Occuity, what do you suppose you’d be doing?
Dr. Robin Taylor: I hope to suppose I’d be doing one thing very related! Innovation and design is what drives me and the healthcare sector is one thing I’m very captivated with. I’ve at all times wished to make use of my abilities to enhance high quality of life.
What’s the most important lesson you’ve learnt to this point constructing Occuity?
Dr. Robin Taylor: Issues at all times take longer than you suppose, however you probably have good individuals round you, you’ll be able to overcome nearly any impediment. We have now assembled an awesome crew.
Dr. Dan Daly: If you’re doing one thing worthwhile, individuals recognize it and purchase into the imaginative and prescient. This results in assist from all types of surprising areas, assist that helps to ease and speed up the journey.
Occuity is nice alternative to spend money on a mission to develop revolutionary non-invasive diabetes screening and monitoring gadgets. Go to Occuity’s marketing campaign web page.
